q&more
My watch list
my.chemie.de  
Login  

News

Producing vaccines without the use of chemicals

© Fraunhofer IZI

The research and pilot facility at Fraunhofer IZI. Before it can be used in industrial vaccine production, the dimensions of the system must be reduced to the size of a refrigerator.

07-Jan-2019: Producing vaccines is a tricky task – especially in the case of inactivated vaccines, in which pathogens must be killed without altering their structure. Until now, this task has generally involved the use of toxic chemicals. Now, however, an innovative new technology developed by Fraunhofer researchers – the first solution of its kind – will use electron beams to produce inactivated vaccines quickly, reproducibly and without the use of chemicals.

Vaccinations against polio, diphtheria, whooping cough and tetanus have been on the list of standard infant vaccinations for decades now. Many vaccines are inactivated vaccines - that is to say, the pathogens they contain have been killed so that they can no longer harm the patient. Despite this, the vaccine provokes an immune response: The body detects a foreign intruder and begins to produce antibodies to ward off infection. To produce these vaccines, pathogens are cultivated in large quantities and then killed using toxic chemicals. The most common of these is formaldehyde - heavily diluted so it doesn’t harm the patient when the vaccination is administered. Nevertheless, there are downsides to even this minimal concentration: The toxin must remain in contact with the pathogen for days or even weeks to take effect, which has a negative impact both on the structure of the pathogen and the reproducibility of the vaccine. And in cases that call for speed – flu vaccines for instance – drug manufacturers are obliged to use higher dosages of formaldehyde. The product must then undergo a time-consuming process of filtration to avoid traces of the toxic chemical being left behind in the vaccine.

Electron beams kill harmful pathogens

Now, pharmaceutical companies will be able to produce inactivated vaccines without the slightest trace of toxic chemicals – quickly and reproducibly. The scientists who developed this process see its greatest potential in the production of vaccines that until now were not amenable to the method of chemical inactivation. The technique was developed jointly by researchers at the Fraunhofer Institutes for Cell Therapy and Immunology IZI, Manufacturing Engineering and Automation IPA, Organic Electronics, Electron Beam and Plasma Technology FEP and Interfacial Engineering and Biotechnology IGB. “Instead of using chemicals to inactivate the pathogens, we employ low-energy electron beams,” explains Fraunhofer IPA team leader Martin Thoma. The accelerated electrons break down the DNA of the pathogens either via direct collisions or through the generation of secondary electrons, which subsequently result in single or double strand breaks. In a nutshell, the electrons fragment the pathogens’ DNA while maintaining their external structure. This is important to trigger an effective immune response.

The challenge arises from the fact that the electrons cannot penetrate very deeply into the suspension containing the pathogens - in fact, for an even dose distribution, liquid levels should not exceed 200 micrometers. Because there were no existing technologies capable of meeting these requirements, Fraunhofer IPA developed two new methods from scratch. In the first method, a cylinder is continuously wetted with the pathogen suspension, irradiated, and the inactivated liquid transferred into a sterile vessel. In other words, there are two reservoirs of liquid: one containing the active and one containing the inactive pathogens - connected to one another via a constantly turning cylindrical vessel or tumbler. “It’s a continuous process that can easily be scaled up for the mass production of vaccines,” says Thoma. The second method is more suited to lab-scale applications, in which small quantities of vaccine are produced for research or drug development purposes. In this instance, the solution containing the pathogens is placed in bags, which are then passed through the electron beam using a patented process.

A collaborative undertaking

This kind of project calls for a range of expertise that is perfectly covered by the four Fraunhofer Institutes involved in the initiative. Researchers at Fraunhofer IZI took responsibility for cultivating the various pathogens – including one for avian flu and one for equine influenza. “Following the irradiation, we also worked with our colleagues at Fraunhofer IGB to determine whether the pathogens had been fully inactivated, thus providing effective vaccine protection,” says Dr. Sebastian Ulbert, head of department at Fraunhofer IZI and the initiator of the project. The expertise in electron beam technology came from researchers at Fraunhofer FEP, who developed a system capable of delivering the low-energy electron beams at precise doses – this is necessary because, while the aim is to reliably inactivate the pathogen, care must also be taken to preserve the pathogen structure so that patients’ immune systems can produce the corresponding antibodies.

The new technology has already been implemented, and not only on the laboratory scale: “In the fall of 2018, a research and pilot facility entered into service here at Fraunhofer IZI. Using our continuous module – the wetted tumbler – we are currently able to produce four liters of vaccine per hour,” says Ulbert. That is not far off industrial scale, given that, for certain vaccines, 15 liters of pathogen suspension can yield a million doses of vaccine.

Discussions are already underway with partners in industry. However, it will be another two to four years before vaccines produced using electron beams can be tested in clinical trials.

Facts, background information, dossiers

  • vaccines
  • vaccine development
  • electron beams

More about Fraunhofer-Institut IZI

  • News

    Biomimetic molecules to program cell mechanics

    Researchers from the Fraunhofer Institute for Cell Therapy and Immunology and Leipzig University are developing a system to enable mechanical cell properties to be precisely modulated and investigated. By drawing on synthetic mimics of proteins in cells, the links between cellular scaffold ... more

More about Fraunhofer-Institut IPA

  • News

    Machine learning algorithm automatically sorts zebrafish eggs

    Zebrafish possess almost all of the same genes we humans do - and that makes their eggs the perfect model organisms for use in genetic and drug research. Previously, samples have had to be prepared manually, which is a very time-consuming task. Now, however, a clever machine learning algori ... more

    Automation to ensure quality in 3D printing

    The genuine hope for Industry 4.0 is pinned on 3D-printed parts, but there are still no quality standards in place for additive manufacturing. Fraunhofer IPA has developed an automated system that enables quality to be automatically checked during printing. Industry partners can test and fu ... more

    Cleanroom on demand

    “Clean Multipurpose Cover” is the world’s first flexible cleanroom system The smallest degree of contamination can lead to major quality issues across many industries. Should, for example, any impurities occur on microchips, space probes and lenses, this can lead to defects or faulty end d ... more

More about Fraunhofer-Institut FEP

  • News

    Organic photodiodes – more economical detectors for the NIR region

    The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP will be introducing a new generation of organic photodiodes on silicon substrates (OPD-on-silicon) during the SEMI European Imaging & Sensors Summit 2017. Optical sensors are pervasive. Domestic life a ... more

    New procedure for producing safe and more effective vaccines

    A consortium of four Fraunhofer Institutes (the Fraunhofer Institute for Cell Therapy and Immunology IZI, Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, Fraunhofer Institute for Manufacturing Engineering and Automation IPA, and the Fraunhofer Institut ... more

More about Fraunhofer-Institut IGB

  • News

    Spray drying: Perfect dosing thanks to drug capsules

    Instant coffee and powdered milk are produced by spray drying. Fraunhofer researchers have adapted this technique to the tricky question of incorporating insoluble substances in core-shell particles. The new method helps reduce the concentration of active ingredients in therapeutic medicati ... more

    Rapid test identifies disease pathogens

    At present, bacteria, fungi or viruses can generally only be detected with certainty by way of elaborate laboratory tests or animal experiments. The food and pharmaceutical industries would like to have faster tests to check their products. Fraunhofer researchers are therefore developing a ... more

    Process analysis in real time

    With a real-time mass spectrometer developed by Fraunhofer researchers, it has become possible for the first time to analyze up to 30 components simultaneously from the gas phase and a liquid, including in-situ analysis. This sensitive measurement system is also suitable for the automated m ... more

More about Fraunhofer-Gesellschaft

  • News

    Precisely fitting bone implants from the printer

    Cancerous tumors, infections or bad fractures can make it necessary to surgically remove bones and insert implants in their place. In collaboration with European partners, Fraunhofer researchers have now developed a technique with which bone implants that are precisely fitting, stable and v ... more

    Machine learning algorithm automatically sorts zebrafish eggs

    Zebrafish possess almost all of the same genes we humans do - and that makes their eggs the perfect model organisms for use in genetic and drug research. Previously, samples have had to be prepared manually, which is a very time-consuming task. Now, however, a clever machine learning algori ... more

    Clean through solar power

    In combination with the right materials, sunbeams can work wonders: they clean building facades and decompose pollutants from the air or in the water. The magic word is photocatalysis. In practice, though, the effectiveness of this „miracle cure“ fluctuates greatly, depending on the materia ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:



Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE